Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326).

Source:http://linkedlifedata.com/resource/pubmed/id/11531286

Download in:

View as

General Info

PMID
11531286